keyword
https://read.qxmd.com/read/38695605/daratumumab-and-antineoplastic-therapy-versus-antineoplastic-therapy-only-for-adults-with-newly-diagnosed-multiple-myeloma-ineligible-for-transplant
#1
REVIEW
Peter Langer, Lukas John, Ina Monsef, Christof Scheid, Vanessa Piechotta, Nicole Skoetz
BACKGROUND: Multiple myeloma (MM) is a haematological malignancy that is characterised by proliferation of malignant plasma cells in the bone marrow. For adults ineligible to receive high-dose chemotherapy and autologous stem cell transplant, the recommended treatment combinations in first-line therapy generally consist of combinations of alkylating agents, immunomodulatory drugs, and proteasome inhibitors. Daratumumab is a CD38-targeting, human IgG1k monoclonal antibody recently developed and approved for the treatment of people diagnosed with MM...
May 2, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38694904/a-case-series-on-safety-and-tolerability-of-human-umbilical-cord-derived-mesenchymal-stem-cells-on-patients-in-malaysia
#2
Basmullah Yusof, Iqmaliza Kamal, Ka Man Lee, Siong Kiat Chai, Xia Lin Zuo, Manickam Ravichandran, Ke Xiang Ding, Neeraj Kumar Fuloria, Seng Kong Tham
Umbilical cord-derived mesenchymal stem cells for regenerative therapy are a promising treatment option for chronic illnesses. Umbilical cord-derived mesenchymal stem cells offer several advantages over other sources, which makes them an attractive option in tissue repair and regeneration. This clinical study describes a 1-year follow-up on the safety and tolerance of umbilical cord-derived mesenchymal stem cell therapy on nine patients in Malaysia. Patients were assessed for adverse effects, and liver function tests were carried out on both pre- and post-treatments...
2024: SAGE Open Medical Case Reports
https://read.qxmd.com/read/38694586/impact-of-sample-type-on-d-dimer-screening
#3
JOURNAL ARTICLE
Ellies Tunjung Sari Maulidyanti, Nur Vita Purwaningsih, Ainutajriani Ainutajriani, Rahma Widyastuti
BACKGROUND: The quality of laboratory test results depends on various factors, including sample type selection. Blood samples, such as whole blood, plasma and serum are commonly used for most clinical laboratory examinations. D-dimer parameters are frequently analysed in haematology laboratories and serve as biomarkers for coagulation activation and fibrinolysis. This study aimed to assess the impact of using different sample types on the quality of D-dimer test results. METHOD: An observational analytical method was used...
April 2024: Malaysian Journal of Medical Sciences: MJMS
https://read.qxmd.com/read/38694583/peripherally-inserted-central-venous-catheter-related-complications-in-adult-patients-with-haematological-malignancy
#4
JOURNAL ARTICLE
Kee Wei Lee, Chin Sum Cheong, Gan Gin Gin
BACKGROUND: Peripherally inserted central venous catheters (PICC) are widely used in patients with haematological malignancies owing to the requirement for prolonged intravenous therapy. However, the growing use of PICCs has resulted in a multitude of complications such as infections and thrombosis, leading to prolonged hospitalisation periods and increased morbidity. This study aimed to determine the incidence of and factors associated with PICC-related complications in patients with haematological malignancies...
April 2024: Malaysian Journal of Medical Sciences: MJMS
https://read.qxmd.com/read/38694396/cytarabine-induced-peripheral-neuropathy-in-a-young-patient-with-acute-myeloid-leukemia-a-case-report
#5
Kshitiz Karki, Sugat Adhikari, Suraj Shrestha, Jenish Bhandari, Bidisha Baral, Aastha Baral
INTRODUCTION AND IMPORTANCE: Cytarabine, a pyrimidine analogue, is commonly used to treat multiple haematological conditions, such as acute leukaemias and lymphomas. One of the rare and less reported complications of cytarabine is peripheral neuropathy, in which peripheral nerves are damaged, often causing weakness, numbness, and pain, usually in the hands and feet. CASE PRESENTATION: The authors report the case of a 17-year-old male who developed a gradual onset of weakness and sensory loss in all four limbs during treatment with a conventional dose of cytarabine for acute myeloid leukaemia...
May 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38694390/pancytopenia-as-a-first-presentation-of-late-onset-systemic-lupus-erythematosus-a-case-report
#6
Ghina Haidar, Naram Khalayli, Tasneem Drie, Mhd Homam Safiah, Maysoun Kudsi
INTRODUCTION: Systemic lupus erythematosus (SLE) is a systemic immune disease that classically occurs in young to middle-aged women and may present with cutaneous, renal, haematologic, neurological, and/or other symptoms at the time of diagnosis. Late-onset SLE or SLE in the elderly is a subtype that differs from classic SLE in terms of age group, clinical symptoms, organ involvement and severity. CASE PRESENTATION: A 63-year-old female noted to have pancytopenia...
May 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38693677/fludarabine-cyclophosphamide-and-rituximab-as-first-line-treatment-in-patients-with-chronic-lymphocytic-leukemia-a-long-term-analysis-of-the-german-cll-study-group-gcllsg-registry
#7
JOURNAL ARTICLE
Nadine Kutsch, Adam Giza, Sandra Robrecht, Janina Stumpf, Anno Federhen, Andrea Stoltefuß, Ursula Vehling-Kaiser, Michael Koenigsmann, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Thomas Illmer, Rudolf Schlag, Steffen Dörfel, Tobias Gaska, Michael Kiehl, Sigrun Müller-Hagen, Enno Moorahrend, Hartmut Linde, Anke Schlenska-Lange, Julia von Tresckow, Kirsten Fischer, Barbara Eichhorst, Michael Hallek, Anna Maria Fink
Long-term data of chronic lymphocytic leukemia (CLL) patients with favorable risk who were treated with fludarabine, cyclophosphamide, and rituximab (FCR) within clinical trials show good efficacy. We here report long-term data collected within the GCLLSG registry. Altogether, 417 CLL patients who received first-line treatment with FCR were analyzed, of which 293 (70.3%) were treated outside of clinical trials. The median observation time from first-line was 95.8 (interquartile range 58.7-126.8) months. Focusing on data of 194 (46...
May 1, 2024: European Journal of Haematology
https://read.qxmd.com/read/38693052/impact-of-prior-treatment-on-selinexor-bortezomib-dexamethasone-outcomes-in-patients-with-relapsed-refractory-multiple-myeloma-extended-follow-up-subgroup-analysis-of-the-boston-trial
#8
JOURNAL ARTICLE
Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella Mesa, Michele Cavo, Meletios Dimopoulos, Martina Bianco, Giovanni Marino Merlo, Charles la Porte, Paul G Richardson, Philippe Moreau
OBJECTIVES: To analyze the impact of prior therapies on outcomes with selinexor, bortezomib, and dexamethasone (SVd) versus bortezomib and dexamethasone (Vd) in 402 patients with relapsed/refractory multiple myeloma (RRMM) in the phase 3 BOSTON trial. METHODS: Post hoc analysis of progression-free survival (PFS), overall survival (OS), and safety for lenalidomide-refractory, proteasome inhibitor (PI)-naïve, bortezomib-naïve, and one prior line of therapy (1LOT) patient subgroups...
May 1, 2024: European Journal of Haematology
https://read.qxmd.com/read/38692983/comparison-of-echocardiography-and-multi-planar-gated-acquisition-scans-for-predicting-cancer-treatment-related-cardiovascular-dysfunction
#9
JOURNAL ARTICLE
Mark T Nolan, Faraz Pathan, Louise Nott, Allison Black, Owen Pointon, Thomas H Marwick
BACKGROUND: Current guidelines recommend using sequential cardiac imaging to monitor for cancer treatment-related cardiac dysfunction (CTRCD) in patients undergoing potentially cardiotoxic chemotherapy. Multiple different imaging cardiac modalities are available and there are few prospective head-to-head comparative studies to help guide treatment. OBJECTIVES: To perform an exploratory prospective cohort study of "real-world" CTRCD comparing multigated acquisition nuclear ventriculography (MUGA) at the referring cancer specialist's discretion with a novel echocardiographic strategy at an Australian tertiary hospital...
April 30, 2024: Heart, Lung & Circulation
https://read.qxmd.com/read/38686463/effect-of-the-sodium-glucose-cotransporter-2-inhibitor-dwp16001-as-an-add-on-therapy-to-insulin-for-diabetic-dogs-a-pilot-study
#10
JOURNAL ARTICLE
Ju-Hyun An, Han-Sol Choi, Ji-Soo Choi, Hyun-Woo Lim, Wan Huh, Ye-In Oh, Joon Seok Park, Jumi Han, Soo Lim, Chae-Young Lim, Tae-Hee Kim, Jae-Bong Moon, Hwa-Young Youn
BACKGROUND: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a novel class of anti-hyperglycaemic agents. OBJECTIVE: This study aimed to evaluate the safety and the adjuvant glycaemic control effect of an SGLT2 inhibitor, DWP16001, in diabetic dogs receiving insulin treatment. METHODS: Nineteen diabetic dogs receiving insulin treatment (NPH, porcine lente and glargine insulin) were divided into two groups according to dosing frequency: DWP TOD group (n = 10) and DWP SID group (n = 9)...
May 2024: Veterinary Medicine and Science
https://read.qxmd.com/read/38685724/liver-steatosis-in-patients-with-transfusion-dependent-thalassaemia
#11
JOURNAL ARTICLE
Paolo Ricchi, Laura Pistoia, Vincenzo Positano, Anna Spasiano, Tommaso Casini, Maria Caterina Putti, Zelia Borsellino, Antonella Cossu, Giuseppe Messina, Petra Keilberg, Carmina Fatigati, Silvia Costantini, Stefania Renne, Giuseppe Peritore, Filippo Cademartiri, Antonella Meloni
We evaluated the prevalence and the clinical associations of liver steatosis (LS) in patients with transfusion-dependent thalassaemia (TDT). We considered 301 TDT patients (177 females, median age = 40.61 years) enrolled in the Extension-Myocardial Iron Overload in Thalassaemia Network, and 25 healthy subjects. Magnetic resonance imaging was used to quantify iron overload and hepatic fat fraction (FF) by T2* technique and cardiac function by cine images. The glucose metabolism was assessed by the oral glucose tolerance test (OGTT)...
April 29, 2024: British Journal of Haematology
https://read.qxmd.com/read/38685577/decreased-rna-binding-protein-heterogeneous-nuclear-ribonucleoprotein-u-improves-multiple-myeloma-sensitivity-to-lenalidomide
#12
JOURNAL ARTICLE
Zhimei Lin, Yue Zhang, Xiang Liu, Hongmei Luo, Qian Li, Qianwen Gao, Xin Wang, Jingjing Wen, Linfeng Li, Yu Feng, Fangfang Wang, Jingcao Huang, Xinyu Zhai, Li Zhang, Ting Niu, Yuhuan Zheng
Multiple myeloma (MM) is an incurable plasma cell cancer in the bone marrow. Immunomodulatory drugs, such as lenalidomide (LEN) and pomalidomide, are backbone agents in MM treatment, and LEN resistance is commonly seen in the MM clinic. In this study, we presented that heterogeneous nuclear ribonucleoprotein U (hnRNPU) affected MM resistance to LEN via the regulation of target mRNA translation. hnRNPULow MM cells exhibited upregulated CRBN and IKZF1 proteins, stringent IKZF1/3 protein degradation upon LEN addition and increased sensitivity to LEN...
April 29, 2024: British Journal of Haematology
https://read.qxmd.com/read/38680738/a-balance-of-clinical-assessment-and-use-of-diagnostic-imaging-a-ct-colonography-comparative-case-report
#13
Justin A Clarke, Jeevon Benning, John Isaacs, Sheree Angell-Clarke
Computer tomography colonography (CTC) is a non-invasive procedure which has replaced barium enema. CTC uses helical images of a cleansed and gas-distended colon for the diagnosis and treatment of colonic neoplasms. This case study compares 2 patients: one with positive pathology (patient A) and another as comparator (patient B) with a similar pathology to discuss and debate possible treatment pathways. Patient (A) CTC showed 2 polyps: 6 mm and 10 mm, which the colorectal surgeons thought only needed follow-up...
July 2024: Radiology Case Reports
https://read.qxmd.com/read/38674248/assessing-the-diagnostic-values-of-the-neutrophil-to-lymphocyte-ratio-nlr-and-systematic-immunoinflammatory-index-sii-as-biomarkers-in-predicting-covid-19-severity-a-multicentre-comparative-study
#14
MULTICENTER STUDY
Anwar A Sayed
COVID-19 has been notoriously unpredictable in its clinical course. Such unpredictability poses a challenge to clinicians in predicting patients who will develop severe cases and possibly die from the infection. This study aims to assess and compare the diagnostic value of the NLR and SII as biomarkers in predicting COVID-19 severity, represented by mortality, with a multicentre comparative study including 855 patients in Saudi Arabia. Descriptive and analytical statistics were used to compare haematological indices between survivors and non-survivors...
April 5, 2024: Medicina
https://read.qxmd.com/read/38670741/evaluation-of-a-machine-learning-model-based-on-laboratory-parameters-for-the-prediction-of-acute-leukaemia-subtypes-a-multicentre-model-development-and-validation-study-in-france
#15
MULTICENTER STUDY
Vincent Alcazer, Grégoire Le Meur, Marie Roccon, Sabrina Barriere, Baptiste Le Calvez, Bouchra Badaoui, Agathe Spaeth, Olivier Kosmider, Nicolas Freynet, Marion Eveillard, Carolyne Croizier, Simon Chevalier, Pierre Sujobert
BACKGROUND: Acute leukaemias are life-threatening haematological cancers characterised by the infiltration of transformed immature haematopoietic cells in the blood and bone marrow. Prompt and accurate diagnosis of the three main acute leukaemia subtypes (ie acute lymphocytic leukaemia [ALL], acute myeloid leukaemia [AML], and acute promyelocytic leukaemia [APL]) is of utmost importance to guide initial treatment and prevent early mortality but requires cytological expertise that is not always available...
May 2024: The Lancet. Digital health
https://read.qxmd.com/read/38668745/venomous-snakebites-in-children-a-10-year-experience-in-south-china
#16
JOURNAL ARTICLE
Qianqin Li, Yan Huang, Youhong Zhang, Liangbo Zeng, Qing Liang, Jiangfu Luo
INTRODUCTION: Many studies have focused on snakebites in adults, but very few have described snakebites in children. METHODS: We reviewed the clinical characteristics and outcomes of children with venomous snakebites aged less than 15 years who presented to a regional medical centre in South China from January 2013 to December 2022. RESULTS: A total of 69 envenomed patients were analyzed in our study; 42 (60.9 per cent) patients were male, and 59 (85...
April 26, 2024: Clinical Toxicology
https://read.qxmd.com/read/38665060/patients-with-aggressive-b-cell-lymphoma-receiving-car-t-cell-therapy-have-a-low-rate-of-severe-infections-despite-lack-of-universal-antibacterial-and-antifungal-prophylaxis
#17
JOURNAL ARTICLE
B Pernas, G Iacoboni, I Los-Arcos, C Carpio, E Márquez-Algaba, M A Sanchez-Salinas, A Albasanz, J Esperalba, B Viñado, I Ruiz Camps, P Barba
OBJECTIVES: Our aim was to describe the frequency and severity of infectious complications after chimeric antigen receptor (CAR) T-cell therapy in patients with large B-cell lymphoma (LBCL). METHODS: We retrospectively reviewed clinical records of LBCL patients treated with CD19-targeted CAR T-cell therapy from July/2018 to December/2021 at our institution, and identified all infectious episodes from CAR T-cell infusion until disease progression, death or last follow-up...
April 26, 2024: European Journal of Haematology
https://read.qxmd.com/read/38664949/guideline-on-the-use-of-predeposit-autologous-donation-prepared-by-the-bsh-blood-transfusion-task-force
#18
JOURNAL ARTICLE
Wendy McSporran, Rekha Anand, Paula Bolton-Maggs, Karen Madgwick, Lorna McLintock, Kelly Nwankiti
No abstract text is available yet for this article.
April 25, 2024: British Journal of Haematology
https://read.qxmd.com/read/38664918/allogeneic-haematopoietic-stem-cell-transplantation-for-adult-t-lymphoblastic-lymphoma-a-real-world-multicentre-analysis-in%C3%A2-china
#19
JOURNAL ARTICLE
Wenxuan Huo, Lu Gao, Kaidi Song, Jiayu Huang, Na Wang, Leqing Cao, Yang Liu, Fengrong Wang, Chuan Li, Xiaoyu Zhu, Xiaojin Wu, Yang Cao, Xiaodong Mo, Xiaoxia Hu
In this multicentre, real-world study, we aimed to identify the clinical outcomes and safety of allogeneic haematopoietic stem cell transplantation (allo-HSCT) in T-lymphoblastic lymphoma (T-LBL). A total of 130 Ann Arbor stage III or IV T-LBL patients (>16 years) treated with allo-HSCT across five transplant centres were enrolled. The 2-year cumulative incidence of disease progression, the probabilities of progression-free survival (PFS), overall survival (OS) and non-relapse mortality (NRM) after allo-HSCT were 21...
April 25, 2024: British Journal of Haematology
https://read.qxmd.com/read/38661269/front-line-and-second-line-treatment-for-mantle-cell-lymphoma-in-clinical-practice-a-multicenter-retrospective-analysis
#20
JOURNAL ARTICLE
Minna Harmanen, Marc Sorigue, Madiha Khan, Roosa Prusila, Tuula Klaavuniemi, Esa Kari, Esa Jantunen, Kaisa Sunela, Aino Rajamäki, Erika Alanne, Hanne Kuitunen, Arja Jukkola, Juan-Manuel Sancho, Outi Kuittinen, Aino Rönkä
BACKGROUND: There are few reports of clinical practice treatment patterns and efficacy in mantle cell lymphoma (MCL). MATERIALS AND METHODS: We retrospectively studied a large, multicenter, cohort of patients with MCL diagnosed between 2000 and 2020 in eight institutions. RESULTS: 536 patients were registered (73% male, median of 70 years). Front-line treatment was based on high-dose cytarabine, bendamustine, and anthracyclines in 42%, 12%, and 15%, respectively...
April 25, 2024: European Journal of Haematology
keyword
keyword
32486
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.